Rice Hall James & Associates, LLC Ani Pharmaceuticals Inc Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 60,375 shares of ANIP stock, worth $3.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

60,375

Previous 60,672 0.49%

Holding current value

$3.4 Million

Previous $3.86 Million 6.78%

% of portfolio

0.21%

Previous 0.25%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$54.33 - $65.72 $16,136 - $19,518	-297 Reduced 0.49%	60,375 $3.6 Million
Q2 2024 Aug 07, 2024	SELL	$58.53 - $68.82 $243,601 - $286,428	-4,162 Reduced 6.42%	60,672 $3.86 Million
Q1 2024 Apr 23, 2024	SELL	$54.2 - $69.69 $4,661 - $5,993	-86 Reduced 0.13%	64,834 $4.48 Million
Q4 2023 Feb 08, 2024	SELL	$48.72 - $65.43 $159,947 - $214,806	-3,283 Reduced 4.81%	64,920 $3.58 Million
Q3 2023 Nov 02, 2023	BUY	$50.28 - $64.61 $1.04 Million - $1.34 Million	20,760 Added 43.76%	68,203 $3.96 Million
Q2 2023 Jul 24, 2023	BUY	$37.29 - $53.83 $1.77 Million - $2.55 Million	47,443 New	47,443 $2.55 Million
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $726,135 - $911,110	-27,526 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $5,986 - $10,020	-200 Reduced 0.72%	27,526 $890,000
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $6,585 - $14,569	-217 Reduced 0.78%	27,726 $1.13 Million
Q4 2019 Jan 29, 2020	SELL	$55.65 - $79.83 $39,288 - $56,359	-706 Reduced 2.46%	27,943 $1.72 Million
Q3 2019 Oct 30, 2019	BUY	$64.7 - $85.39 $151,074 - $199,385	2,335 Added 8.87%	28,649 $2.09 Million
Q2 2019 Aug 01, 2019	SELL	$67.77 - $82.2 $108,432 - $131,520	-1,600 Reduced 5.73%	26,314 $2.16 Million
Q1 2019 May 01, 2019	SELL	$45.83 - $70.54 $56,141 - $86,411	-1,225 Reduced 4.2%	27,914 $1.97 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $121,327 - $166,328	2,947 Added 11.25%	29,139 $1.31 Million
Q3 2018 Oct 25, 2018	SELL	$52.95 - $71.34 $327,548 - $441,309	-6,186 Reduced 19.11%	26,192 $1.48 Million
Q2 2018 Aug 02, 2018	BUY	$56.38 - $68.08 $1.83 Million - $2.2 Million	32,378 New	32,378 $2.16 Million

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Ani Pharmaceuticals Inc Transaction History